Erschienen in:
15.09.2017 | Review
Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review
verfasst von:
Vindana Chibabhai, Trusha Nana, Norma Bosman, Teena Thomas, Warren Lowman
Erschienen in:
Infection
|
Ausgabe 1/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose
There is currently a paucity of published literature focused on the treatment of infections caused by NDM-producing organisms.
Methods
We describe a case of a bacteraemia caused by an extensively drug-resistant (XDR) New Delhi metallo-β-lactamase (NDM)-producing Serratia marcescens and review the treatment options for XDR NDM-producing Enterobacteriaceae.
Results
Infections caused by New Delhi beta-lactamase (NDM)-producing Enterobacteriaceae are becoming increasingly prevalent worldwide. The presence of the enzyme results in multidrug-resistant and extensively drug-resistant phenotypes which often pose a treatment challenge. Despite this challenge, case reports and series have demonstrated good clinical outcomes with numerous treatment options in comparison to infections due to KPC-producing Enterobacteriaceae.
Conclusions
Further good-quality research focused on the treatment of NDM-producing Enterobacteriaceae is warranted.